Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06010641

Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3)

Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3): a Prospective, Randomized, Open-label, Blinded-endpoint, Multi-center Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
General Hospital of Shenyang Military Region · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The effect of head position as a nonpharmacological therapy on acute ischemic stroke (AIS) remains inconclusive. Recent HOPES2 (Head dOwn-Position for acutE moderate ischemic Stroke with large artery atherosclerosis) suggest the safety, feasibility, and potential benefit of the head-down position (HDP) in acute ischemic stroke. The current study aims to investigate the efficacy and safety of HDP in acute moderate ischemic stroke patients with large artery atherosclerosis.

Conditions

Interventions

TypeNameDescription
OTHERhead-down position-20° Trendelenburg as an adjunct to guideline-based treatment,

Timeline

Start date
2024-01-10
Primary completion
2026-10-30
Completion
2026-10-30
First posted
2023-08-24
Last updated
2025-03-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06010641. Inclusion in this directory is not an endorsement.